Maria Del Ben Selected Research

Sterol Esterase (Hormone-Sensitive Lipase)

1/2020	Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
1/2020	Correction to: Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
12/2019	Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
8/2019	Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
12/2017	Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.
1/2017	Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
7/2015	Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Del Ben Research Topics

Disease

32	Non-alcoholic Fatty Liver Disease 03/2022 - 07/2011
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 01/2003
6	Insulin Resistance 03/2022 - 07/2011
6	Fibrosis (Cirrhosis) 09/2020 - 07/2014
6	Fatty Liver 12/2017 - 07/2011
6	Hypercholesterolemia 04/2013 - 05/2003
5	Liver Diseases (Liver Disease) 09/2020 - 07/2014
5	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2003
5	Alcoholic Fatty Liver 01/2017 - 04/2014
4	Inflammation (Inflammations) 03/2022 - 10/2016
4	Atrial Fibrillation 01/2021 - 06/2015
3	Weight Loss (Weight Reduction) 03/2022 - 01/2012
3	Atherosclerosis 07/2021 - 01/2017
3	Obesity 04/2014 - 05/2003
2	Endotoxemia 05/2022 - 01/2019
2	Hypertension (High Blood Pressure) 03/2022 - 01/2003
2	Dyslipidemias (Dyslipidemia) 03/2022 - 01/2017
2	Metabolic Diseases (Metabolic Disease) 03/2022 - 05/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 07/2014
2	Cryptogenic Cirrhosis 12/2019 - 01/2017
2	Cholesterol Ester Storage Disease 08/2019 - 11/2015
2	Wolman Disease (Wolman's Disease) 08/2019 - 12/2017
2	Obstructive Sleep Apnea 01/2018 - 05/2015
2	Thrombosis (Thrombus) 03/2016 - 11/2014
2	Hepatomegaly 11/2015 - 01/2003
2	Myocardial Infarction 06/2015 - 06/2015
2	Body Weight (Weight, Body) 06/2012 - 01/2012
1	Weight Gain 03/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Diabetes Complications 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2021
1	Gallstones (Gallstone) 01/2021
1	Hemorrhage 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2019

Drug/Important Bio-Agent (IBA)

7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 04/2014
7	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2020 - 07/2015
5	Transaminases (Aminotransferases)IBA 01/2022 - 11/2015
5	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2003
5	CholesterolIBA 12/2020 - 07/2011
5	Insulin (Novolin)FDA Link 01/2020 - 01/2003
4	oxidized low density lipoproteinIBA 07/2021 - 12/2012
4	LipopolysaccharidesIBA 09/2020 - 01/2019
4	AntioxidantsIBA 09/2020 - 01/2012
4	EnzymesIBA 01/2020 - 01/2003
4	Vitamin K FDA Link 03/2016 - 06/2015
3	Triglycerides (Triacylglycerol)IBA 03/2022 - 07/2011
3	Peptides (Polypeptides)IBA 07/2021 - 04/2014
3	LDL CholesterolIBA 07/2021 - 06/2012
3	HDL LipoproteinsIBA 12/2020 - 07/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2003
3	IsoprostanesIBA 01/2019 - 12/2012
3	NADP (NADPH)IBA 01/2019 - 12/2012
3	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2015 - 01/2005
3	Atorvastatin (Lipitor)FDA Link 04/2013 - 11/2004
2	Phospholipases (Phospholipase)IBA 03/2022 - 11/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 10/2018
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020 - 03/2014
2	Toll-Like Receptor 4IBA 09/2020 - 01/2017
2	SilymarinIBA 09/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2017
2	zonulinIBA 01/2019 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 11/2018 - 12/2012
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2017 - 09/2007
2	Vitamin D FDA LinkGeneric 06/2016 - 07/2011
2	omega-Chloroacetophenone (Mace)IBA 03/2016 - 12/2015
2	Keratin-18 (Keratin 18)IBA 10/2015 - 04/2014
2	Vitamin E FDA LinkGeneric 10/2015 - 01/2012
2	AnticoagulantsIBA 06/2015 - 06/2015
2	AdiponectinIBA 04/2014 - 01/2012
2	CD40 Ligand (CD40L)IBA 11/2006 - 01/2005
1	Olive OilIBA 05/2022
1	glucokinase regulatory proteinIBA 03/2022
1	AcyltransferasesIBA 03/2022
1	CollagenIBA 03/2022
1	Complement C3 (C3 Complement)IBA 03/2022
1	High Fructose Corn SyrupIBA 03/2022
1	ElementsIBA 03/2022
1	FructoseIBA 03/2022
1	Sucrose (Saccharose)IBA 03/2022
1	Uric Acid (Urate)IBA 03/2022
1	StilbenesIBA 01/2022
1	Anthocyanins (Anthocyanin)IBA 01/2022
1	LignansIBA 01/2022
1	FlavonoidsIBA 01/2022
1	PolyphenolsIBA 01/2022
1	Proprotein Convertase 9IBA 07/2021
1	Ezetimibe (Zetia)FDA Link 07/2021
1	Oxidants (Oxidizing Agents)IBA 09/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	oleuropeinIBA 01/2020
1	Pyridinolcarbamate (P23)IBA 01/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 08/2019
1	CytokinesIBA 07/2019

Therapy/Procedure

5	Mediterranean Diet 05/2022 - 08/2015
4	Therapeutics 01/2021 - 06/2015
3	Continuous Positive Airway Pressure 05/2020 - 01/2018
2	Liver Transplantation 01/2020 - 01/2003
1	Cholecystectomy 01/2021